CAPTRUST Financial Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.28M | Buy |
123,736
+33,142
| +37% | +$1.8M | 0.01% | 793 |
|
|
2026
Q1 | $5.68M | Buy |
90,594
+30,504
| +51% | +$2.44M | 0.01% | 718 |
|
|
2025
Q4 | $5.73M | Sell |
60,090
-31
| -0.1% | -$3.04K | 0.01% | 629 |
|
|
2025
Q3 | $5.87M | Sell |
60,121
-7,401
| -11% | -$766K | 0.01% | 591 |
|
|
2025
Q2 | $7.25M | Buy |
67,522
+5,849
| +9% | +$592K | 0.02% | 531 |
|
|
2025
Q1 | $6.22M | Buy |
61,673
+7,093
| +13% | +$714K | 0.02% | 536 |
|
|
2024
Q4 | $4.88M | Buy |
54,580
+8,316
| +18% | +$732K | 0.01% | 553 |
|
|
2024
Q3 | $3.88M | Sell |
46,264
-5,556
| -11% | -$438K | 0.01% | 601 |
|
|
2024
Q2 | $3.99M | Buy |
51,820
+1,332
| +3% | +$97.5K | 0.01% | 564 |
|
|
2024
Q1 | $3.46M | Sell |
50,488
-34,875
| -41% | -$2.24M | 0.01% | 603 |
|
|
2023
Q4 | $4.93M | Buy |
85,363
+10,167
| +14% | +$543K | 0.02% | 565 |
|
|
2023
Q3 | $3.97M | Buy |
75,196
+21,158
| +39% | +$1.11M | 0.02% | 601 |
|
|
2023
Q2 | $2.92M | Buy |
54,038
+273
| +0.5% | +$14.3K | 0.01% | 692 |
|
|
2023
Q1 | $2.69M | Buy |
53,765
+6,298
| +13% | +$297K | 0.01% | 647 |
|
|
2022
Q4 | $2.2M | Buy |
47,467
+10,064
| +27% | +$436K | 0.01% | 689 |
|
|
2022
Q3 | $1.45M | Buy |
37,403
+3,948
| +12% | +$158K | 0.01% | 778 |
|
|
2022
Q2 | $1.25M | Buy |
33,455
+5,926
| +22% | +$241K | 0.01% | 747 |
|
|
2022
Q1 | $1.22M | Buy |
27,529
+2,801
| +11% | +$121K | 0.01% | 768 |
|
|
2021
Q4 | $1.05M | Sell |
24,728
-151
| -0.6% | -$6.34K | 0.01% | 794 |
|
|
2021
Q3 | $1.08M | Buy |
24,879
+2,527
| +11% | +$112K | 0.01% | 721 |
|
|
2021
Q2 | $956K | Sell |
22,352
-1,573
| -7% | -$66.2K | 0.01% | 734 |
|
|
2021
Q1 | $925K | Buy |
23,925
+10,110
| +73% | +$383K | 0.01% | 721 |
|
|
2020
Q4 | $497K | Sell |
13,815
-1,426
| -9% | -$51.4K | 0.01% | 833 |
|
|
2020
Q3 | $586K | Buy |
15,241
+3,478
| +30% | +$134K | 0.01% | 670 |
|
|
2020
Q2 | $415K | Buy |
11,763
+1,965
| +20% | +$70.8K | 0.01% | 772 |
|
|
2020
Q1 | $296K | Sell |
9,798
-3,113
| -24% | -$122K | 0.01% | 728 |
|
|
2019
Q4 | $585K | Buy |
12,911
+3,708
| +40% | +$155K | 0.01% | 635 |
|
|
2019
Q3 | $374K | Buy |
9,203
+511
| +6% | +$21.6K | 0.01% | 456 |
|
|
2019
Q2 | $374K | Sell |
8,692
-844
| -9% | -$32.5K | 0.01% | 445 |
|
|
2019
Q1 | $366K | Buy |
9,536
+265
| +3% | +$10.1K | 0.01% | 402 |
|
|
2018
Q4 | $328K | Buy |
9,271
+41
| +0.4% | +$1.49K | 0.02% | 356 |
|
|
2018
Q3 | $355K | Buy |
9,230
+6,101
| +195% | +$213K | 0.02% | 351 |
|
|
2018
Q2 | $102K | Buy |
3,129
+1,594
| +104% | +$48.1K | 0.01% | 505 |
|
|
2018
Q1 | $41K | Sell |
1,535
-1,215
| -44% | -$33K | ﹤0.01% | 654 |
|
|
2017
Q4 | $68K | Buy |
+2,750
| New | +$75.8K | ﹤0.01% | 522 |
|
Other funds holding BSX
CAPTRUST Financial Advisors's BSX Position: Q2 2026 in Review
CAPTRUST Financial Advisors increased its Boston Scientific (BSX) stake by 37% in Q2 2026, buying an estimated $1.8M and bringing the position to 123,736 shares worth $5.28M. The position accounts for 0.01% of the portfolio, ranked #793.
CAPTRUST Financial Advisors first reported a position in BSX in Q4 2017 and has held it in 35 quarters since. The position peaked at $7.25M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- CAPTRUST Financial Advisors held 123,736 shares of Boston Scientific worth $5.28M as of Q2 2026.
- CAPTRUST Financial Advisors bought 33,142 Boston Scientific shares in Q2 2026, an estimated $1.8M.
- Boston Scientific made up 0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #793 holding.
- CAPTRUST Financial Advisors first reported a position in Boston Scientific in Q4 2017 and has held it in 35 quarters since.
- CAPTRUST Financial Advisors's Boston Scientific position peaked at $7.25M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.